(Q45611409)

14 December 2017

title

Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women (English)

1 reference

14 December 2017

10

Robert D Burk

1 reference

14 December 2017

5

Howard D Strickler

1 reference

14 December 2017

6

Howard Minkoff

1 reference

14 December 2017

Linda Ahdieh-Grant

1

1 reference

14 December 2017

Rui Li

2

1 reference

14 December 2017

Alexandra M Levine

3

1 reference

14 December 2017

L Stewart Massad

4

1 reference

14 December 2017

Michael Moxley

7

1 reference

14 December 2017

Joel Palefsky

8

1 reference

14 December 2017

Henry Sacks

9

1 reference

14 December 2017

Stephen J Gange

11

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Journal of the National Cancer Institute

14 December 2017

published in

1 reference

14 December 2017

volume

96

1 reference

14 December 2017

issue

14

1 reference

14 December 2017

page(s)

1070-1076

1 reference

The causal relation between human papillomavirus and cervical cancer

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Effectiveness of highly active antiretroviral therapy among HIV-1 infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Do we still need a cohort study of women with HIV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Human papillomavirus infection in women infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Incidence of cervical squamous intraepithelial lesions in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Marginal structural models and causal inference in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

Distinguishing efficacy, individual effectiveness and population effectiveness of therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH192

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH192

1 reference

14 December 2017

1 reference